Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Margaret Pass is active.

Publication


Featured researches published by Margaret Pass.


Clinical Infectious Diseases | 2004

Hospitalizations and Deaths Due to Salmonella Infections, FoodNet, 1996–1999

Malinda Kennedy; Rodrigo G. Villar; Duc J. Vugia; Therese Rabatsky-Ehr; Monica M. Farley; Margaret Pass; Kirk E. Smith; Perry Smith; Paul R. Cieslak; Beth Imhoff; Patricia M. Griffin

Nontyphoidal Salmonella causes a higher proportion of food-related deaths annually than any other bacterial pathogen in the United States. We reviewed 4 years (1996-1999) of population-based active surveillance data on laboratory-confirmed Salmonella infections from the Emerging Infections Programs Foodborne Diseases Active Surveillance Network (FoodNet), to determine the rates of hospitalization and death associated with Salmonella infection. Overall, 22% of infected persons were hospitalized, with the highest rate (47%) among persons aged >60 years. Fifty-eight deaths occurred, for an estimated annual incidence of 0.08 deaths/100,000 population. These deaths accounted for 38% of all deaths reported through FoodNet from 1996 through 1999, and they occurred primarily among adults with serious underlying disease. Although Salmonella infection was seldom listed as a cause of death on hospital charts and death certificates, our chart review suggests that Salmonella infection contributed to these deaths.


The Journal of Infectious Diseases | 2002

Recurrent Invasive Pneumococcal Disease in Individuals with Human Immunodeficiency Virus Infection

M. Catherine McEllistrem; Aaron B. Mendelsohn; Margaret Pass; John A. Elliott; Cynthia G. Whitney; John A. Kolano; Lee H. Harrison

The proportion of relapses and reinfections that are potentially preventable by vaccine in human immunodeficiency virus (HIV)-infected persons with recurrent pneumococcal disease is unknown. Isolates from HIV-infected individuals from Baltimore with recurrent pneumococcal invasive disease were collected from 1 January 1995 through 31 December 2000. Serotyping and pulsed-field gel electrophoresis were performed. From 1 January 1995 through 31 December 1998, 14.9% (404/2717) of those who had a pneumococcal infection were HIV infected. The recurrence rate among HIV-infected individuals was 6.4-fold higher than that among individuals without HIV infection (P<.01). Among recurrent infections in 41 individuals, there were 42 reinfections and 6 relapses. All relapses and 91% (70/77) of reinfections were due to serotypes covered by the 23-valent pneumococcal polysaccharide vaccine. Reinfection was more common than relapse among HIV-infected individuals with recurrent pneumococcal disease. Although a substantial proportion of recurrent pneumococcal infections was potentially preventable by vaccine, creating an effective vaccine may be challenging for this population.


Emerging Infectious Diseases | 2003

Aggregated Antibiograms and Monitoring of Drug-Resistant Streptococcus pneumoniae

Chris Van Beneden; Catherine Lexau; Wendy Baughman; Brenda Barnes; Nancy M. Bennett; P. Maureen Cassidy; Margaret Pass; Lisa B. Gelling; Nancy L. Barrett; Elizabeth R. Zell; Cynthia G. Whitney

Community-specific antimicrobial susceptibility data may help monitor trends among drug-resistant Streptococcus pneumoniae and guide empiric therapy. Because active, population-based surveillance for invasive pneumococcal disease is accurate but resource intensive, we compared the proportion of penicillin-nonsusceptible isolates obtained from existing antibiograms, a less expensive system, to that obtained from 1 year of active surveillance for Georgia, Tennessee, California, Minnesota, Oregon, Maryland, Connecticut, and New York. For all sites, proportions of penicillin-nonsusceptible isolates from antibiograms were within 10 percentage points (median 3.65) of those from invasive-only isolates obtained through active surveillance. Only 23% of antibiograms distinguished between isolates intermediate and resistant to penicillin; 63% and 57% included susceptibility results for erythromycin and extended-spectrum cephalosporins, respectively. Aggregating existing hospital antibiograms is a simple and relatively accurate way to estimate local prevalence of penicillin-nonsusceptible pneumococcus; however, antibiograms offer limited data on isolates with intermediate and high-level penicillin resistance and isolates resistant to other agents.


Emerging Infectious Diseases | 2005

Nosocomial Malaria and Saline Flush

Sanjay K. Jain; Deborah Persaud; Trish M. Perl; Margaret Pass; Kathleen M. Murphy; John M. Pisciotta; Peter F. Scholl; James F. Casella; David J. Sullivan

An investigation of malaria in a US patient without recent travel established Plasmodium falciparum molecular genotype identity in 2 patients who shared a hospital room. P. falciparum can be transmitted in a hospital environment from patient to patient by blood inoculum if standard precautions are breached.


Clinical Infectious Diseases | 2002

Distribution of penicillin-nonsusceptible pneumococcal clones in the Baltimore metropolitan area and variables associated with drug resistance

M. Catherine McEllistrem; Aaron B. Mendelsohn; Margaret Pass; John A. Elliott; Cynthia G. Whitney; Bernadette A. Albanese; Lee H. Harrison

We assessed the distribution of the clonal groups (as determined by pulsed-field gel electrophoresis) of penicillin-nonsusceptible Streptococcus pneumoniae that caused invasive pneumococcal infection in the Baltimore metropolitan area during 1995 and 1996. Although S. pneumoniae caused invasive disease in individuals from a variety of demographic groups and locations, strains isolated during the season in which respiratory infections are most common were more likely to be from clonal groups associated with penicillin resistance than from other groups.


JAMA | 2001

Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998 Opportunities for Prevention in the Conjugate Vaccine Era

Katherine Robinson; Wendy Baughman; Gretchen Rothrock; Nancy L. Barrett; Margaret Pass; Catherine Lexau; Barbara Damaske; Karen Stefonek; Brenda Barnes; Jan E. Patterson; Elizabeth R. Zell; Anne Schuchat; Cynthia G. Whitney


JAMA | 2001

Macrolide Resistance Among Invasive Streptococcus pneumoniae Isolates

Terri B. Hyde; David S. Stephens; Duc J. Vugia; Margaret Pass; Susan R. Johnson; Nancy L. Barrett; William Schaffner; Paul R. Cieslak; Peggy S. Maupin; Elizabeth R. Zell; James H. Jorgensen; Richard R. Facklam; Cynthia G. Whitney


JAMA | 2001

Invasive Meningococcal Disease in Adolescents and Young Adults

Lee H. Harrison; Margaret Pass; Aaron B. Mendelsohn; Mücahit Eğri; Nancy E. Rosenstein; Alicia Bustamante; Jafar Razeq; Jeffrey C. Roche


Emerging Infectious Diseases | 2000

Candida dubliniensis fungemia: the first four cases in North America.

Mary E. Brandt; Lee H. Harrison; Margaret Pass; Andre N. Sofair; Sharon Huie; Ren-Kai Li; Christine J. Morrison; David W. Warnock; Rana Hajjeh


American Journal of Infection Control | 2006

Infection control program disparities between acute and long-term care facilities in Maryland

Brenda J. Roup; Jeffrey C. Roche; Margaret Pass

Collaboration


Dive into the Margaret Pass's collaboration.

Top Co-Authors

Avatar

Cynthia G. Whitney

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Trish M. Perl

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

Sara E. Cosgrove

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elizabeth R. Zell

National Center for Immunization and Respiratory Diseases

View shared research outputs
Top Co-Authors

Avatar

John A. Elliott

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nancy L. Barrett

Connecticut Agricultural Experiment Station

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge